Determinan Lama Rawat Inap Pasien Diabetes Mellitus Berdasarkan Data Klaim JKN

Ismi Irfiyanti Fachruddin; Ulfa Diya Atiqa; Nur Asmi

doi:10.25047/j-remi.v7i4.6829

Penulis

Ismi Irfiyanti Fachruddin Universitas Negeri Makassar
Ulfa Diya Atiqa Universitas Negeri Makassar
Nur Asmi Universitas Megarezky Makassar

DOI:

https://doi.org/10.25047/j-remi.v7i4.6829

Kata Kunci:

BPJS Health Claims Data, Diabetes Mellitus, INA-CBGs, Indonesia's National Health Insurance (JKN), Length of Stay

Abstrak

Lama rawat inap pasien Diabetes mellitus (DM) dalam sistem Jaminan Kesehatan Nasional (JKN) masih bervariasi dan berpotensi mencerminkan ketidakefisienan pelayanan. Namun, faktor-faktor yang paling berperan terhadap variasi tersebut belum sepenuhnya teridentifikasi secara komprehensif berdasarkan data populasi. Penelitian ini bertujuan untuk menganalisis determinan lama rawat inap pada pasien DM menggunakan data klaim BPJS Kesehatan tahun 2024. Penelitian ini menggunakan desain observasional analitik dengan pendekatan cross-sectional. Sampel penelitian terdiri atas 28.576 pasien DM yang menjalani rawat inap di fasilitas kesehatan rujukan tingkat lanjut. Lama rawat inap dikategorikan menjadi ≤3 hari dan >3 hari. Analisis data dilakukan secara deskriptif, uji Chi-Square, dan regresi logistik biner. Hasil penelitian menunjukkan bahwa 42,5% pasien menjalani lama rawat inap >3 hari. Tingkat keparahan kasus merupakan determinan yang paling dominan, dengan pasien pada kategori berat memiliki peluang lebih tinggi mengalami lama rawat inap >3 hari. Selain itu, kepemilikan rumah sakit berhubungan secara signifikan dengan variasi lama rawat inap. Kesimpulan penelitian ini menunjukkan bahwa lama rawat inap dipengaruhi oleh faktor klinis dan faktor sistem pelayanan. Oleh karena itu, diperlukan peningkatan manajemen kasus berdasarkan tingkat keparahan serta evaluasi efisiensi pelayanan antar fasilitas kesehatan guna mendukung pengendalian biaya dalam sistem JKN.

Referensi

[1] X. Lin et al., “Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025,” Sci. Rep., vol. 10, no. 1, pp. 1–11, Sep. 2020, doi: 10.1038/s41598-020-71908-9.

[2] R. Lozano et al., “Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019,” Lancet, vol. 396, no. 10258, pp. 1250–1284, Oct. 2020, doi: 10.1016/S0140-6736(20)30750-9.

[3] American Diabetes Association, “Economic Costs of Diabetes in the U.S. in 2017,” Diabetes Care, vol. 41, no. 5, pp. 917–928, May 2018, doi: 10.2337/dci18-0007.

[4] A. E. Micah et al., “Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050,” Lancet, vol. 398, no. 10308, pp. 1317–1343, Oct. 2021, doi: 10.1016/S0140-6736(21)01258-7.

[5] K. Hajjar, L. Lillo, D. A. Martinez, M. Hermosilla, and N. Risko, “Association between universal health coverage and the disease burden of acute illness and injury at the global level,” BMC Public Health, vol. 23, no. 1, pp. 1–7, Apr. 2023, doi: 10.1186/s12889-023-15671-2.

[6] Y. Chen, X. Zhang, J. Yan, Xue-Tang, M. Qian, and X. Ying, “Impact of Diagnosis-Related Groups on Inpatient Quality of Health Care: A Systematic Review and Meta-Analysis,” Inq. J. Heal. Care Organ. Provision, Financ., vol. 60, pp. 1–16, Jan. 2023, doi: 10.1177/00469580231167011.

[7] S.-W. Cheng, C.-Y. Wang, and Y. Ko, “Costs and Length of Stay of Hospitalizations due to Diabetes-Related Complications,” J. Diabetes Res., vol. 2019, pp. 1–6, Sep. 2019, doi: 10.1155/2019/2363292.

[8] Y. Jiang, B. Rodgers, K. Damiris, C. Choi, and S. Ahlawat, “The effects of diabetes mellitus on clinical outcomes of hospitalized patients with acute diverticulitis,” Eur. J. Gastroenterol. Hepatol., vol. 33, no. 11, pp. 1354–1360, Nov. 2021, doi: 10.1097/MEG.0000000000001895.

[9] F. Akiboye et al., “Impact of the Diabetes Inpatient Care and Education (DICE) project on length of stay and mortality,” Diabet. Med., vol. 37, no. 2, pp. 277–285, Feb. 2020, doi: 10.1111/dme.14062.

[10] F. O. Syed, F. U. Rehman, I. Amin, S. A. Ali, B. J. Rind, and B. Ahmed, “Diabetes Mellitus Does Not Predict Discharge in Hospitalized Patients With Acute Pyelonephritis: A Study From Karachi, Pakistan,” Cureus, vol. 12, no. 10, pp. 1–9, Oct. 2020, doi: 10.7759/cureus.11024.

[11] L. Dulipsingh, H. Bakeri, D. Wakefield, B. Shanaman, and L. Cook, “Impact of Diabetes on Hospitalized Patients With Chronic Medical Conditions,” Diabetes Spectr., vol. 34, no. 3, pp. 283–291, Aug. 2021, doi: 10.2337/ds20-0088.

[12] M. A. Sajjad et al., “Comparison of incidence, rate and length of all-cause hospital admissions between adults with normoglycaemia, impaired fasting glucose and diabetes: a retrospective cohort study in Geelong, Australia,” BMJ Open, vol. 8, no. 3, pp. 1–11, Mar. 2018, doi: 10.1136/bmjopen-2017-020346.

[13] H. Fahlevi, I. Irsyadillah, M. Indriani, and R. S. Oktari, “DRG-based payment system and management accounting changes in an Indonesian public hospital: exploring potential roles of big data analytics,” J. Account. Organ. Chang., vol. 18, no. 2, pp. 325–345, Mar. 2022, doi: 10.1108/JAOC-10-2020-0179.

[14] R. R. Nugraha et al., “Predicting the cost of COVID-19 treatment and its drivers in Indonesia: analysis of claims data of COVID-19 in 2020-2021,” Health Econ. Rev., vol. 12, no. 1, pp. 1–10, Aug. 2022, doi: 10.1186/s13561-022-00392-w.

[15] H. E. Rogers, A. R. Akiteng, G. Mutungi, A. S. Ettinger, and J. I. Schwartz, “Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards,” BMC Health Serv. Res., vol. 18, no. 1, pp. 1–13, Dec. 2018, doi: 10.1186/s12913-018-3426-x.

[16] S. G. Vyas, N. S. Badnerkar, N. A. Chhajed, and S. S. Vyas, “Clinical assessment of etiological risk factors of chronic kidney disease in patients admitted for dialysis to a tertiary care hospital,” Asian J. Med. Sci., vol. 14, no. 9, pp. 115–120, Sep. 2023, doi: 10.3126/ajms.v14i9.54428.

[17] E. J. Zhao et al., “A long wait: barriers to discharge for long length of stay patients,” Postgrad. Med. J., vol. 94, no. 1116, pp. 546–550, Oct. 2018, doi: 10.1136/postgradmedj-2018-135815.

[18] D. Aulia, S. F. Ayu, and N. H. Nasution, “Analisis Upaya Rumah Sakit dalam Menutupi Kekurangan Biaya Klaim Indonesia Case Base Group (INA-CBGs) Yang Dihitung dengan Metode Activities Base Costing pada Rumah Sakit Swasta Kelas C di Kota Medan Tahun 2017,” J. Ekon. Kesehat. Indones., vol. 1, no. 4, pp. 159–166, Nov. 2017, doi: 10.7454/eki.v1i4.1783.

[19] D. M. Wardhana, N. Widajanti, and J. Ichwani, “Hubungan Komponen Comprehensive Geriatric Assessment dan Sarkopenia pada Usia Lanjut,” J. Penyakit Dalam Indones., vol. 6, no. 4, pp. 188–195, Jan. 2019, doi: 10.7454/jpdi.v6i4.370.

[20] S. Satibi, T. M. Andayani, D. Endarti, I. P. T. Suwantara, N. P. Wintariani, and N. P. D. Agustini, “Comparison of Real Cost Versus the Indonesian Case Base Groups (INZ-CBGs) Tariff Rates Among Patients of High- Incidence Cancers Under the National Health Insurance Scheme,” Asian Pacific J. Cancer Prev., vol. 20, no. 1, pp. 117–122, Jan. 2019, doi: 10.31557/APJCP.2019.20.1.117.